Lisa Read

439 total citations
10 papers, 215 citations indexed

About

Lisa Read is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Epidemiology. According to data from OpenAlex, Lisa Read has authored 10 papers receiving a total of 215 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Public Health, Environmental and Occupational Health, 4 papers in Pharmacology and 3 papers in Epidemiology. Recurrent topics in Lisa Read's work include Malaria Research and Control (5 papers), Trypanosoma species research and implications (2 papers) and Research on Leishmaniasis Studies (2 papers). Lisa Read is often cited by papers focused on Malaria Research and Control (5 papers), Trypanosoma species research and implications (2 papers) and Research on Leishmaniasis Studies (2 papers). Lisa Read collaborates with scholars based in United States, Australia and France. Lisa Read's co-authors include Bryan Smith, Mark Hickman, Norma Roncal, Diana Caridha, Richard J. Sciotti, Qigui Li, Sean R. Marcsisin, John D. Clements, Qiang Zeng and Elizabeth B. Norton and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Infection and Immunity.

In The Last Decade

Lisa Read

10 papers receiving 209 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa Read United States 8 148 36 33 32 29 10 215
Le Hong Thai United Kingdom 5 219 1.5× 54 1.5× 34 1.0× 17 0.5× 47 1.6× 5 311
Aung Myint Thu Thailand 6 208 1.4× 44 1.2× 26 0.8× 36 1.1× 20 0.7× 19 279
Viengxay Vanisaveth Laos 10 266 1.8× 33 0.9× 14 0.4× 24 0.8× 39 1.3× 14 299
Jean-Bertin Bukasa Kabuya Zambia 10 209 1.4× 34 0.9× 18 0.5× 63 2.0× 22 0.8× 20 282
P Sookto Thailand 10 369 2.5× 43 1.2× 31 0.9× 21 0.7× 68 2.3× 11 402
Ngo Viet Thanh Vietnam 7 324 2.2× 31 0.9× 26 0.8× 13 0.4× 69 2.4× 9 345
Phillip Rosenthal United States 7 218 1.5× 31 0.9× 12 0.4× 27 0.8× 20 0.7× 8 295
Hans D. Pohle Germany 6 155 1.0× 110 3.1× 102 3.1× 28 0.9× 23 0.8× 11 331
Kyin Hla Aye Myanmar 7 237 1.6× 34 0.9× 31 0.9× 14 0.4× 53 1.8× 11 280
Paul Sondo Burkina Faso 9 247 1.7× 28 0.8× 23 0.7× 11 0.3× 34 1.2× 23 286

Countries citing papers authored by Lisa Read

Since Specialization
Citations

This map shows the geographic impact of Lisa Read's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Read with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Read more than expected).

Fields of papers citing papers by Lisa Read

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Read. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Read. The network helps show where Lisa Read may publish in the future.

Co-authorship network of co-authors of Lisa Read

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Read. A scholar is included among the top collaborators of Lisa Read based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Read. Lisa Read is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
González, Víctor H., Janet H. Ransom, Charles Scott, et al.. (2021). Long-term safety of the tafenoquine antimalarial chemoprophylaxis regimen: A 12-month, randomized, double-blind, placebo-controlled trial. Travel Medicine and Infectious Disease. 45. 102211–102211. 7 indexed citations
3.
Ransom, Janet H., et al.. (2017). Tafenoquine for malaria prophylaxis in adults: An integrated safety analysis. Travel Medicine and Infectious Disease. 17. 19–27. 20 indexed citations
5.
Li, Qigui, Lisa Xie, Diana Caridha, et al.. (2017). Comparative Susceptibility of Different Mouse Strains to Liver-Stage Infection With Plasmodium berghei Sporozoites Assessed Using In Vivo Imaging. Military Medicine. 182(S1). 360–368. 5 indexed citations
6.
Caridha, Diana, Thomas H. Hudson, Thierry Lang, et al.. (2017). Use of Optical Imaging Technology in the Validation of a New, Rapid, Cost-Effective Drug Screen as Part of a TieredIn VivoScreening Paradigm for Development of Drugs To Treat Cutaneous Leishmaniasis. Antimicrobial Agents and Chemotherapy. 61(4). 15 indexed citations
7.
Milner, Erin, Jonathan Berman, Diana Caridha, et al.. (2016). Cytochrome P450 2D-mediated metabolism is not necessary for tafenoquine and primaquine to eradicate the erythrocytic stages of Plasmodium berghei. Malaria Journal. 15(1). 588–588. 18 indexed citations
8.
Leed, Susan E., Norma Roncal, Jacob D. Johnson, et al.. (2015). Antileishmanial Activity of Compounds Derived from the Medicines for Malaria Venture Open Access Box Against Intracellular Leishmania major Amastigotes. American Journal of Tropical Medicine and Hygiene. 94(2). 340–347. 26 indexed citations
9.
Marcsisin, Sean R., Jason Sousa, Gregory A. Reichard, et al.. (2014). Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds. Malaria Journal. 13(1). 2–2. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026